Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Verastem (VSTM) Revenue (2018 - 2025)

Historic Revenue for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to $11.2 million.

  • Verastem's Revenue changed N/A to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 million, marking a year-over-year increase of 7035.27%. This contributed to the annual value of $10.0 million for FY2024, which is 34160.43% up from last year.
  • As of Q3 2025, Verastem's Revenue stood at $11.2 million.
  • Verastem's Revenue's 5-year high stood at $11.2 million during Q3 2025, with a 5-year trough of -$1.1 million in Q1 2024.
  • For the 5-year period, Verastem's Revenue averaged around $1.7 million, with its median value being $251000.0 (2021).
  • Its Revenue has fluctuated over the past 5 years, first crashed by 2812500.0% in 2023, then surged by 99206.07% in 2024.
  • Over the past 5 years, Verastem's Revenue (Quarter) stood at $545000.0 in 2021, then plummeted by 100.73% to -$4000.0 in 2022, then tumbled by 28125.0% to -$1.1 million in 2023, then soared by 985.74% to $10.0 million in 2024, then rose by 12.42% to $11.2 million in 2025.
  • Its Revenue stands at $11.2 million for Q3 2025, versus $2.1 million for Q2 2025 and -$192000.0 for Q1 2025.